81 related articles for article (PubMed ID: 10908046)
1. Striatal kinetic modeling of FDOPA with a cerebellar-derived constraint on the distribution of volume of 30MFD: a PET investigation using non-human primates.
Shoghi-Jadid K; Huang SC; Stout DB; Yee RE; Yeh EL; Farahani KF; Satyamurthy N; Phelps ME; Barrio JR
J Cereb Blood Flow Metab; 2000 Jul; 20(7):1134-48. PubMed ID: 10908046
[TBL] [Abstract][Full Text] [Related]
2. Effects of large neutral amino acid concentrations on 6-[F-18]Fluoro-L-DOPA kinetics.
Stout DB; Huang SC; Melega WP; Raleigh MJ; Phelps ME; Barrio JR
J Cereb Blood Flow Metab; 1998 Jan; 18(1):43-51. PubMed ID: 9428304
[TBL] [Abstract][Full Text] [Related]
3. Distribution volume of 3-O-methyl-6.
Stout DB; Huang SC; Namavari M; Satyamurthy N; Yee RE; Barrio JR
J Cereb Blood Flow Metab; 2000 Dec; 20(12):1717-24. PubMed ID: 11129788
[TBL] [Abstract][Full Text] [Related]
4. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
Ishikawa T; Dhawan V; Chaly T; Robeson W; Belakhlef A; Mandel F; Dahl R; Margouleff C; Eidelberg D
J Cereb Blood Flow Metab; 1996 Sep; 16(5):854-63. PubMed ID: 8784230
[TBL] [Abstract][Full Text] [Related]
5. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
[TBL] [Abstract][Full Text] [Related]
6. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
[TBL] [Abstract][Full Text] [Related]
7. Combined FDOPA and 3OMFD PET studies in Parkinson's disease.
Dhawan V; Ishikawa T; Patlak C; Chaly T; Robeson W; Belakhlef A; Margouleff C; Mandel F; Eidelberg D
J Nucl Med; 1996 Feb; 37(2):209-16. PubMed ID: 8667046
[TBL] [Abstract][Full Text] [Related]
8. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
Kumakura Y; Vernaleken I; Gründer G; Bartenstein P; Gjedde A; Cumming P
J Cereb Blood Flow Metab; 2005 Jul; 25(7):807-19. PubMed ID: 15729292
[TBL] [Abstract][Full Text] [Related]
9. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.
Ishikawa T; Dhawan V; Chaly T; Margouleff C; Robeson W; Dahl JR; Mandel F; Spetsieris P; Eidelberg D
J Nucl Med; 1996 Feb; 37(2):216-22. PubMed ID: 8667047
[TBL] [Abstract][Full Text] [Related]
11. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDOPA kinetics in brain tumors.
Schiepers C; Chen W; Cloughesy T; Dahlbom M; Huang SC
J Nucl Med; 2007 Oct; 48(10):1651-61. PubMed ID: 17873130
[TBL] [Abstract][Full Text] [Related]
13. Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain--an approach using MRI-aided spatial normalization.
Nagano AS; Ito K; Kato T; Arahata Y; Kachi T; Hatano K; Kawasumi Y; Nakamura A; Yamada T; Abe Y; Ishigaki T
Neuroimage; 2000 Jun; 11(6 Pt 1):760-6. PubMed ID: 10860800
[TBL] [Abstract][Full Text] [Related]
14. 6-fluoroDOPA metabolism in rat striatum: time course of extracellular metabolites.
DeJesus OT; Haaparanta M; Solin O; Nickles RJ
Brain Res; 2000 Sep; 877(1):31-6. PubMed ID: 10980240
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
Cumming P; Léger GC; Kuwabara H; Gjedde A
J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
[TBL] [Abstract][Full Text] [Related]
16. Evidence for reduced arterial plasma input, prolonged lung retention and reduced lung monoamine oxidase in smokers.
Logan J; Fowler JS
Nucl Med Biol; 2005 Jul; 32(5):521-9. PubMed ID: 15982583
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive assessment of aromatic L-amino acid decarboxylase activity in aging rhesus monkey brain in vivo.
Dejesus OT; Endres CJ; Shelton SE; Nickles RJ; Holden JE
Synapse; 2001 Jan; 39(1):58-63. PubMed ID: 11071710
[TBL] [Abstract][Full Text] [Related]
18. Developmental changes in the activities of aromatic amino acid decarboxylase and catechol-O-methyl transferase in the porcine brain: a positron emission tomography study.
Brust P; Walter B; Hinz R; Füchtner F; Müller M; Steinbach J; Bauer R
Neurosci Lett; 2004 Jul; 364(3):159-63. PubMed ID: 15196667
[TBL] [Abstract][Full Text] [Related]
19. Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria.
Landvogt C; Mengel E; Bartenstein P; Buchholz HG; Schreckenberger M; Siessmeier T; Scheurich A; Feldmann R; Weglage J; Cumming P; Zepp F; Ullrich K
J Cereb Blood Flow Metab; 2008 Apr; 28(4):824-31. PubMed ID: 17971791
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.
Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
J Cereb Blood Flow Metab; 2001 Nov; 21(11):1342-53. PubMed ID: 11702049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
